ARWR Latest Headlines

Arrowhead's Novel RNAi Therapy Targets Alzheimer's at the Genetic Level—Phase 1/2a Study Kicks Off

Market Chameleon (Mon, 8-Dec 7:58 AM)

Cautious Optimism for Arrowhead Pharmaceuticals Amid Competitor’s Positive Obesity Treatment Data

at www.tipranks.com (Mon, 8-Dec 4:45 PM)

Paramount Skydance, Wave Life Sciences, Ocular Therapeutix, Carvana And Other Big Stocks Moving Higher On Monday

at www.benzinga.com (Mon, 8-Dec 12:33 PM)

Arrowhead Pharmaceuticals (ARWR) Receives a Buy from Jefferies

at www.tipranks.com (Fri, 5-Dec 8:46 AM)

Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR), Cytokinetics (CYTK) and Denali Therapeutics (DNLI)

at www.tipranks.com (Fri, 5-Dec 5:20 AM)

Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR) and Humana (HUM)

at www.tipranks.com (Fri, 5-Dec 5:10 AM)

Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Arrowhead Pharmaceuticals (ARWR) and uniQure (QURE)

at www.tipranks.com (Fri, 5-Dec 3:10 AM)

FDA Breakthrough Therapy Designation for Plozasiran Highlights Arrowhead’s Innovative Approach to Severe Hypertriglyceridemia

Market Chameleon (Tue, 2-Dec 8:36 AM)

FDA Approval and Financial Turnaround Highlight Arrowhead Pharmaceuticals’ Breakout Year

Market Chameleon (Wed, 26-Nov 11:45 AM)